The Latest Analyst Ratings for Edwards Lifesciences
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 16 analysts have published their opinion on Edwards Lifesciences (NYSE:EW) stock, with an average 12-month price target of $94.0. The average price target has increased by 4.98% over the past month.
May 30, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edwards Lifesciences (NYSE:EW) has received 16 analyst opinions in the past 3 months, with an average 12-month price target of $94.0, which has increased by 4.98% over the past month.
The average 12-month price target for Edwards Lifesciences has increased by 4.98% over the past month, indicating a positive sentiment among analysts. This could lead to a short-term increase in the stock price as investors may view the higher price target as a sign of growth potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100